IVIG for refractory dysphagia in Antisynthetase syndrome: A truth hard to swallow.

Autor:	Alnoukari, Mais, De La Garza, Oziel Garza, Al Gburi, Karrar, Patel, Niral, Lopez, Henderson, Shamim, Muhammad, Kwang, Henry
Předmět:	INTRAVENOUS immunoglobulins TREATMENT effectiveness SYNDROMES APHASIA DEGLUTITION
Zdroj:	Clinical Case Reports; Nov2022, Vol. 10 Issue 11, p1-4, 4p
Abstrakt:	Refractory dysphasia could be the main symptom of Antisynthetase syndrome (ASS). IVIG may have a major impact in the successful treatment of dysphasia in patients with ASS. In our patient with ASS, IVIG treatment was an unreplaceable treatment option, and the patient regains her ability to swallow within 2 days. Refractory dysphasia could be the main symptom of Antisynthetase syndrome (ASS). IVIG may have a major impact in the successful treatment of dysphasia in patients with ASS. A cure can be possible within just 2 days of IVIG treatment. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.